Dominik A. Heim
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 113 publications
Pseudo-Richter transformation in a patient with chronic lymphocytic leukemia after cessation of fixed duration venetoclax/ibrutinib treatment.
Journal: Annals of hematology
Published: January 16, 2026
Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland.
Journal: Swiss medical weekly
Published: October 23, 2025
Successful treatment with Tislelizumab and Zanubrutinib in a patient with relapsed/refractory, CD19/CD20 negative Richter's transformed CLL.
Journal: Bone marrow transplantation
Published: August 06, 2025
IGLV3-21R110-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia.
Journal: Haematologica
Published: February 27, 2025
Busulfan Once Versus Four Times Daily: Impact on Pharmacokinetics, Organ Toxicities and Survival After Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: December 31, 2024
Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trial.
Journal: Blood
Published: September 16, 2024
Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs.
Journal: Swiss medical weekly
Published: May 15, 2024
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan.
Journal: Bone marrow transplantation
Published: December 21, 2023
Influence of comorbidities on outcome in 1102 patients with an allogeneic hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation
Published: November 28, 2023
Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT.
Journal: Transplantation and cellular therapy
Published: September 17, 2023
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021.
Journal: Hematological oncology
Published: August 28, 2023
CD4+ CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas.
Journal: Bone marrow transplantation
Published: April 23, 2023
Last Updated: 09/26/2026